BioNexus Gene Lab Corp. (NASDAQ: BGLC) ("BGLC" or the "Company"), a biotechnology company advancing precision diagnostics and gene-based technologies, today announced the formal completion of its ...

Blood tests that promise to spot cancer before symptoms appear are racing toward clinics, pitched as a simple vial of blood ...

Grail Inc. is downgraded from Speculative Buy to Hold after a rapid share price surge from $55 to $100. Click here to read my ...

The prospect of diagnosing cancer through painless methods—such as a simple AI-assisted blood or urine test that detects tiny particles known as exosomes—is becoming increasingly realistic. Scientists ...

An AI-assisted analysis of tiny particles circulating in blood or urine—scientifically known as exosomes—could one day enable ...

A new documentary series is putting Manchester's 'pioneering' cancer research in the national spotlight. The episode Clues in ...

Use of MRI-guided focused ultrasound with standard chemotherapy is safe and may improve outcomes for people with glioblastoma ...

ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced the ...

A new documentary series is putting Manchester's 'pioneering' cancer research in the national spotlight. The episode Clues in the Blood airs on Channel 4 on December 4 at 10pm and is part of the ...

Foresight Diagnostics, a leader in ultrasensitive minimal residual disease (MRD) detection technology, today announced the presentation of multiple lymphoma studies featuring Foresight CLARITY™ ...

Dave Coulier, 66, who gained widespread adulation with the sitcom Full House (1987-1995), has recently been diagnosed with ...

The prostate-specific antigen (PSA) is an enzyme produced by cells in the prostate. One of its roles is to break down the ...